We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+12.19%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.15B
AUM Growth
-$3.94B
Cap. Flow
-$4.44B
Cap. Flow %
-106.94%
Top 10 Hldgs %
33.3%
Holding
6,378
New
470
Increased
1,548
Reduced
3,513
Closed
532

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$263M
2
AAPL icon
Apple
AAPL
+$226M
3
AMZN icon
Amazon
AMZN
+$127M
4
NVDA icon
NVIDIA
NVDA
+$115M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$80.9M

Sector Composition

Rank Sector Weight
1 Technology 26.16%
2 Consumer Discretionary 9.21%
3 Communication Services 8.49%
4 Financials 7.96%
5 Industrials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIVS
4151
VivoSim Labs
VIVS
$1.16M
$7.74K ﹤0.01%
626
+195
+45% +$2.43K
SPWR icon
4152
SunPower Inc
SPWR
$46.4M
$7.74K ﹤0.01%
12,870
+8,717
+210% +$9.63K
CABA icon
4153
Cabaletta Bio
CABA
$465M
$7.73K ﹤0.01%
453
-2,170
-83% -$46.6K
CPHC icon
4154
Canterbury Park Holding Corp
CPHC
$80.8M
$7.72K ﹤0.01%
331
-416
-56% -$9.53K
LITS
4155
Lite Strategy Inc
LITS
$31.4M
$7.72K ﹤0.01%
1,931
+604
+46% +$2.74K
XBIL icon
4156
US Treasury 6 Month Bill ETF
XBIL
$745M
$7.72K ﹤0.01%
+154
New +$7.71K
PNTG icon
4157
Pennant Group
PNTG
$1.34B
$7.71K ﹤0.01%
393
-6,335
-94% -$107K
QNCX icon
4158
Quince Therapeutics
QNCX
$31.8M
$7.71K ﹤0.01%
36
+2
+6% +$497
CLPR
4159
Clipper Realty
CLPR
$50.9M
$7.71K ﹤0.01%
1,596
-721
-31% -$3.56K
RMTI icon
4160
Rockwell Medical
RMTI
$29.6M
$7.7K ﹤0.01%
464
+195
+72% +$2.83K
OSBC icon
4161
Old Second Bancorp
OSBC
$1.31B
$7.7K ﹤0.01%
556
-11,117
-95% -$155K
VBIO
4162
Valion Bio
VBIO
$709K
$7.7K ﹤0.01%
362
+223
+160% +$5.15K
NXXT
4163
NextNRG Inc
NXXT
$54.2M
$7.69K ﹤0.01%
1,800
+648
+56% +$2.63K
OLO
4164
DELISTED
Olo Inc
OLO
$7.69K ﹤0.01%
1,401
-18,572
-93% -$101K
CEF icon
4165
Sprott Physical Gold and Silver Trust
CEF
$8.32B
$7.69K ﹤0.01%
378
HCTI icon
4166
Healthcare Triangle
HCTI
$3.51M
0
KLRS
4167
Kalaris Therapeutics
KLRS
$93.8M
$7.68K ﹤0.01%
442
-187
-30% -$3.05K
RPC
4168
Ridgepost Capital
RPC
$972M
$7.68K ﹤0.01%
912
-4,629
-84% -$40.6K
BKKT icon
4169
Bakkt Inc
BKKT
$336M
$7.67K ﹤0.01%
667
-359
-35% -$9.65K
MAPS
4170
DELISTED
WM TECHNOLOGY INC A
MAPS
$7.67K ﹤0.01%
5,763
-3,915
-40% -$3.63K
OSPN icon
4171
OneSpan
OSPN
$609M
$7.66K ﹤0.01%
659
-8,230
-93% -$84.5K
IXHL icon
4172
Incannex Healthcare
IXHL
$37.9M
$7.66K ﹤0.01%
71
-16
-18% -$1.92K
GIC icon
4173
Global Industrial
GIC
$1.49B
$7.66K ﹤0.01%
171
-2,700
-94% -$115K
PMCB icon
4174
PharmaCyte Biotech
PMCB
$5.88M
$7.65K ﹤0.01%
3,229
+1,354
+72% +$2.93K
MSPR
4175
DELISTED
MSP Recovery Inc
MSPR
$7.64K ﹤0.01%
64
-14
-18% -$2.62K

Similar funds

Tower Research Capital (TRC)'s Q1 2024 Portfolio in Review

As of Q1 2024, Tower Research Capital (TRC) held 6,378 positions worth $4.15B, down 49% from $8.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.44B in Q1 2024, closing 532 positions and reducing 3,513 holdings. Its most notable exit was State Street Financial Select Sector SPDR ETF, an estimated $49.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares S&P Small-Cap 600 Growth ETF worth $3.77M.

  • Tower Research Capital (TRC)'s largest Q1 2024 buy was iShares S&P Small-Cap 600 Growth ETF: 28,851 shares worth $3.77M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q1 2024, an estimated $61.6M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2024 reduction was Microsoft, cutting an estimated $263M.
  • Tower Research Capital (TRC) fully exited State Street Financial Select Sector SPDR ETF in Q1 2024, selling an estimated $49.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 33% of its $4.15B portfolio in Q1 2024.
  • Tower Research Capital (TRC) opened 470 new positions and closed 532 in Q1 2024.
  • Tower Research Capital (TRC)'s portfolio value fell 49% quarter-over-quarter to $4.15B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.